Search Results
242 items found for "POTS"
Posts (197)
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
The gravity of this regulation becomes even more apparent when we consider the potential consequences ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells, 10(10), 2509.
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
adding and subtracting molecular contacts between the ligand and the receptor to obtain the required potency As seen below in Figure 1, natural ligands do not make use of all the potential binding contacts with A unique and important feature of Orion’s discovery process is that the initial search for potent target Orion’s CCR2 antagonist analog (OB-004), discovered in only 6 months, is considerably more potent than rapid success, obtaining not only best-in-class antagonists with strong in vivo efficacy, but also potent
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
October 2022 Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent Finally, we validated A2BAR as a potential pharmacological tool in CRC, using selective antagonists,
Other Pages (45)
- CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
< GPCR News < GPCRs in Oncology and Immunology CCR6 as a Potential Target for Therapeutic Antibodies This review highlights the potential as a therapeutic target of the CCR6 receptor in numerous diseases
- Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil chemoattractant
< GPCR News < GPCRs in Oncology and Immunology Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil Here, we characterized the role for heterodimer and show that the Cxcl1-Cxcl2 heterodimer is a potent
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Further, we identified interactors such as BIRC3, TRAF6, and SRC genes, with potential implications for Additionally, receiver operator characteristic curve analysis suggested these genes' potential as biomarkers compounds-ampelopsin, ellagic acid, colchicine, epigallocatechin-3-gallate, cucurbitacin B, and evodin-as potential